Dutch prime Bruno Bruins has urged drugmakers to clarify the criteria used to set drug prices, DutchNews.nl reported Tuesday.
The minister stated that society "cannot accept that healthcare costs mount up so much as to be unaffordable."
"What bothers me is that we are not allowed to know why we have to pay so much," Bruins remarked, adding "we get no explanation. No insight into the price calculation. And I consider that to be unacceptable."
The minister expressed plans to meet with an unnamed drugmaker which has increased the prices of drugs up to €150,000 per patient per year, adding that he would take steps including going public.
The news comes after foreign drugmakers including Gilead Sciences, Johnson & Johnson and Merck & Co. accused the Netherlands of attempting to undermine the business environment by forcing down drug prices in February.
To read more NewsPoints articles, click here.